Manish Kohli - Researcher Profile | RDL Research Database

Publications

2 shown

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos , Yu‐Hui Chen , Michael A. Carducci +15 more

Purpose Docetaxel added to androgen-deprivation therapy (ADT) significantly increases the longevity of some patients with metastatic hormone-sensitive prostate cancer. Herein, w...

2018 Journal of Clinical Oncology 1049 citations

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak , Catherine M. Tangen , Maha Hussain +11 more

The improvement in median survival of nearly two months with docetaxel and estramustine, as compared with mitoxantrone and prednisone, provides support for this approach in men ...

2004 New England Journal of Medicine 3663 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,712
Institution: Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-9735-6614

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.